Missing/wrong data?
Log in to edit
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
scientific article published on 30 December 2003
Author/s
author: Johannes Schetelig, Gunilla Enblad, Hans Hagberg
Work details
Publication date
December 30, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.